{
  "id": 2598,
  "label": "GABA augmenting agent therapy",
  "model": {
    "label": "Mondo Disease Ontology (MONDO)",
    "source": 0
  },
  "type_id": 0,
  "reference_id": "MAXO:0000206",
  "properties": {
    "definition": "Treatment with a substance, such as agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function, used for its pharmacological actions on GABAergic systems."
  },
  "isLeaf": false,
  "isRoot": false,
  "child_count": 1,
  "parents": [
    {
      "id": 2584,
      "label": "anticonvulsant agent therapy",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        2605
      ],
      "type_id": 0,
      "properties": {
        "definition": "Treatment with a drug used to prevent seizures or reduce their severity."
      },
      "child_count": 2,
      "reference_id": "MAXO:0000167"
    },
    {
      "id": 2637,
      "label": "neurotransmitter agent therapy",
      "isLeaf": false,
      "isRoot": false,
      "parents": [
        2575
      ],
      "type_id": 0,
      "properties": {
        "definition": "Use of a drug or agent that modulates neurotransmitter signaling."
      },
      "child_count": 4,
      "reference_id": "MAXO:0001336"
    }
  ],
  "children": [
    {
      "id": 2632,
      "label": "GABA modulator therapy",
      "isLeaf": true,
      "isRoot": false,
      "parents": [
        2598
      ],
      "type_id": 0,
      "properties": {
        "definition": "Use of a drug or agent that does not act as agonist or antagonist but does affect GABA-ionophore complex signaling."
      },
      "child_count": 0,
      "reference_id": "MAXO:0001322"
    }
  ],
  "roots": [
    {
      "id": 2584,
      "label": "anticonvulsant agent therapy"
    },
    {
      "id": 2637,
      "label": "neurotransmitter agent therapy"
    }
  ]
}